Pricing Log in Create free account

Kyverna Therapeutics, Inc. (KYTX) vs Ocugen, Inc. (OCGN)

Kyverna Therapeutics, Inc. and Ocugen, Inc. are both Biotechnology companies. Kyverna Therapeutics, Inc. and Ocugen, Inc. are of similar size ($285.1M and $276.9M). Kyverna Therapeutics, Inc. has the higher net margin (0.00% vs −1,367.6%) and the higher return on invested capital (0.00% vs 0.00%). Across the 11 metrics below, Kyverna Therapeutics, Inc. leads on 6 and Ocugen, Inc. on 5.

Valuation

Metric KYTX OCGN Biotechnology median
P/E n/m n/m 10.60
P/S n/m 66.01 9.40
P/B 1.78 n/m 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales n/m 48.75 9.02
Earnings yield (60.62%) (21.57%) (32.88%)
Free cash flow yield (53.83%) (20.26%) (23.13%)

Profitability

Metric KYTX OCGN Biotechnology median
Gross margin — 100.00% 68.51%
Operating margin 0.00% (1,444.47%) 0.00%
Net margin 0.00% (1,367.61%) 0.00%
Free cash flow margin 0.00% (1,337.16%) 0.00%
Return on equity (87.24%) 923.92% (51.96%)
Return on assets (68.40%) (78.91%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric KYTX OCGN Biotechnology median
Revenue growth (TTM) — (11.01%) 6.76%
EPS growth (last fiscal year) (9.31%) (15.00%) 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric KYTX OCGN Biotechnology median
Debt to equity 0.15 (0.10) 0.00
Current ratio 9.06 0.77 4.97
Net debt to EBITDA 1.51 (0.17) 1.01

Dividend

Metric KYTX OCGN Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric KYTX OCGN Biotechnology median
Market cap 285.10m 276.88m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack